Painful gynaecomastia secondary to cyclosporine A and tacrolimus in a patient with focal segmental glomerulosclerosis.
Francisco J
FJ
Borrego-Utiel
M del Pilar
Mdel P
Pérez-del Barrio
Manuel
M
Polaina-Rusillo
Josefa
J
Borrego-Hinojosa
D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D005221:Fatigue / Q000139:chemically induced; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000188:drug therapy*; D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D008297:Male; D059373:Mastodynia / Q000139:chemically induced*; D008875:Middle Aged; D018908:Muscle Weakness / Q000139:chemically induced; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011507:Proteinuria / Q000209:etiology; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D000959:Antihypertensive Agents; D016572:Cyclosporine; D003520:Cyclophosphamide; D009173:Mycophenolic Acid; D011241:Prednisone; D016559:Tacrolimus